HHealth Read More Patients who stop GLP-1 drugs often restart or try alternativesMarch 17, 2026 A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
HHealth Read More Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefitMarch 9, 2026 A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
HHealth Read More Engineered lettuce may turn injectable GLP-1 therapies into oral pillsMarch 7, 2026 Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
HHealth Read More How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?March 4, 2026 A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
TTechnology Read More Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesityFebruary 25, 2026 Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
HHealth Read More Weight loss drug tirzepatide may lower the risk of diabetic retinopathyFebruary 12, 2026 The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of…
HHealth Read More Unprocessed beef does not worsen metabolic health in prediabetesFebruary 2, 2026 A controlled crossover trial finds that short-term consumption of unprocessed beef is on par with poultry for glucose…
HHealth Read More Improving survival in people with severe psychiatric disordersJanuary 26, 2026 An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
HHealth Read More Diabetes drugs linked to slower frailty progression in older adultsDecember 4, 2025 A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
HHealth Read More WHO releases first guideline on the use of GLP-1 therapies for treating obesityDecember 2, 2025 To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
HHealth Read More Stopping GLP-1 drugs before pregnancy leads to more weight gainDecember 1, 2025 New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
HHealth Read More Searches for “Ozempic face” surge as people look for filler-based solutionsNovember 21, 2025 New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…